Patents by Inventor Xiao Shen

Xiao Shen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110085794
    Abstract: An apparatus comprising a plurality of optical transmitters coupled to a fiber, a signal generator coupled to the optical transmitters and configured to provide a single pilot tone to the optical transmitters, and a processor positioned within a feedback loop between the fiber and the optical transmitters, the processor configured to adjust a wavelength for each of the optical transmitters to lock the wavelengths. An apparatus comprising at least one processor configured to implement a method comprising receiving an optical signal comprising a pilot tone, detecting an amplitude and a phase of the pilot tone, calculating a quadrature term using the amplitude and the phase, and wavelength locking the optical signal using the quadrature term.
    Type: Application
    Filed: October 14, 2009
    Publication date: April 14, 2011
    Applicant: Futurewei Technologies, Inc.
    Inventors: Hongbing LEI, Xiao A. SHEN, Yu Sheng BAI
  • Publication number: 20110085975
    Abstract: The invention features a class of 2-nitroimidazole compounds with a secondary basic nitrogen atom and a linker bearing one or more therapeutic agents, cytotoxic agents, detectable labels, or chelating groups. In particular, the invention provides 2-nitroimidazole compounds containing a cluster of boron atoms for use in boron neutron capture therapy (BNCT). The 2-nitroimidazole compounds can be used to treat hypoxic conditions, including, e.g., cancer, inflammation, and ischemia. The weakly basic 2-nitroimidazole compounds target to hypoxic tissue and provide increased tissue concentration overall.
    Type: Application
    Filed: November 29, 2010
    Publication date: April 14, 2011
    Applicant: NATURAL PHARMACIA INTERNATIONAL, INC.
    Inventors: David Y-W Lee, Xiao-Shen Ji, James A. Raleigh
  • Patent number: 7842278
    Abstract: The invention features a class of 2-nitroimidazole compounds with a secondary basic nitrogen atom and a linker bearing one or more therapeutic agents, cytotoxic agents, detectable labels, or chelating groups. In particular, the invention provides 2-nitroimidazole compounds containing a cluster of boron atoms for use in boron neutron capture therapy (BNCT). The 2-nitroimidazole compounds can be used to treat hypoxic conditions, including, e.g., cancer, inflammation, and ischemia. The weakly basic 2-nitroimidazole compounds target to hypoxic tissue and provide increased tissue concentration overall.
    Type: Grant
    Filed: October 27, 2006
    Date of Patent: November 30, 2010
    Assignee: Natural Pharmacia International, Inc.
    Inventors: David Y-W Lee, Xiao-Shen Ji, James A. Raleigh
  • Publication number: 20100232462
    Abstract: An apparatus comprising a plurality of laser dice and a heat sink positioned between the laser dice and thermally coupled to the laser dice. Also included is an apparatus comprising a chip comprising a laser core, a stopper at least partially defining a groove, wherein the stopper and the groove are positioned adjacent to the chip, and a heater located between the laser core and the groove.
    Type: Application
    Filed: May 4, 2009
    Publication date: September 16, 2010
    Applicant: FUTUREWEI TECHNOLOGIES, INC.
    Inventors: Xiao A. Shen, Yu Sheng Bai
  • Publication number: 20090217402
    Abstract: Methods and compositions are provided for modulating the activity of macrophage and macrophage-like cells, particularly by modulating the peptidase activity of such cells. In certain aspects, methods are provided for enhancing or suppressing the immune function of a host by increasing or decreasing, respectively, expression of a target peptidase in host macrophage and macrophage-like cells. Such methods for enhancing or suppressing the immune function of a host by increasing or inhibiting (suppressing or silencing) expression of a target peptidase in host macrophage and macrophage-like cells find use in methods for treating and/or preventing a number of diseases and conditions, including cancer, viral and/or bacterial infection, Alzheimer's disease, tissue transplant rejection, autoimmune diseases, and chronic inflammatory diseases.
    Type: Application
    Filed: May 18, 2006
    Publication date: August 27, 2009
    Applicant: Emory University
    Inventors: Kenneth Bernstein, Xiao Shen
  • Publication number: 20080102026
    Abstract: The invention features a class of 2-nitroimidazole compounds with a secondary basic nitrogen atom and a linker bearing one or more therapeutic agents, cytotoxic agents, detectable labels, or chelating groups. In particular, the invention provides 2-nitroimidazole compounds containing a cluster of boron atoms for use in boron neutron capture therapy (BNCT). The 2-nitroimidazole compounds can be used to treat hypoxic conditions, including, e.g., cancer, inflammation, and ischemia. The weakly basic 2-nitroimidazole compounds target to hypoxic tissue and provide increased tissue concentration overall.
    Type: Application
    Filed: October 27, 2006
    Publication date: May 1, 2008
    Inventors: David Y-W Lee, Xiao-Shen Ji, James A. Raleigh
  • Publication number: 20070280688
    Abstract: An upgradeable optical hub and hub upgrade can be provided. The upgradeable hub can separate an incoming signal into various components and provide a segment of the incoming signal to a port for a hub upgrade. The hub can drop, for example, four channels to four external nodes. Hub upgrade can separate an incoming signal into various bands, and can drop, for example, four channels to four external nodes. The upgradeable hub, thus, can be upgraded by adding the hub upgrade, without the need for discarding the original hub when performing a hub upgrade.
    Type: Application
    Filed: April 23, 2007
    Publication date: December 6, 2007
    Inventor: Xiao Shen
  • Patent number: 5381362
    Abstract: A high-speed, high-throughput matched optical filter for processing data that allows for rapid reprogramming to change the reference signal or signals. A coherent time-domain optical memory system includes a coherent time-domain optical storage material (18) and a laser (16) for providing pulses of optical radiation in coherent time-domain optical storage relation with the storage material. One or more reference signals are first stored in the material by modulating one or more of the laser pulses with the reference signals and writing these pulses on the storage material (18) in close succession with their associated write pulses as is customary in coherent time-domain optical memories. The reference signals are phase encoded before they are stored. Another laser pulse modulated with the signal to be processed is then applied to the storage material. The echo signal induced by this signal pulse takes the form of the correlation of the reference pulse with the signal pulse.
    Type: Grant
    Filed: July 30, 1993
    Date of Patent: January 10, 1995
    Assignee: SRI International
    Inventors: Xiao An Shen, Yu Sheng Bai, Eric M. Pearson